2m 2m 2m 2m 2m 2m 2m
TEVAPHARMIND SP ADR (TEVA)
NYSE
$36.68-$0.42 (-1.12%)
Price as of Sep 11, 2026 7:50 PM EDT- $43.2BMarket Cap
- 86.10%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
TEVAPHARMIND SP ADR (TEVA)
$36.68-$0.42 (-1.12%)
TEVA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $37.09 | ||
Change | +$0.74 (+2.04%) | ||
Open | $36.46 | ||
High | $37.11 | ||
Low | $36.06 | ||
Previous Close | $36.35 | ||
Volume | 2,855,423 | ||
30-Day Average Volume | 4,877,536 | ||
1-Week Change | 2.01% | ||
1-Month Change | 1.67% | ||
1-Year Change | 86.10% | ||
3-Year Change | 269.42% | ||
5-Year Change | 303.59% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $39.9B | ||
Market Cap | $43.2B | ||
Enterprise Value | $56.2B | ||
Period: QTR TTM FY | |||
Revenue | $4.1B | ||
Net Income | -$576.0M | ||
Free Cash Flow | $306.0M | ||
EBIT | -$455.0M | ||
EBITDA | -$214.0M | ||
Net Working Capital | -$1.9B | ||
EPS | -$0.49 | ||
Enterprise Value/EBITDA | -262 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 6 | ||
P/E | -76 | ||
PEG | 0 | ||
Price/Free Cash Flow | 141 | ||
Price/Operating Cash Flow | 105 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 11/27/2017 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 12/06/2002 | ||
Earnings & Revenue